2017 Multidisciplinary Thoracic Cancers Symposium Press Kit


  • See researchers at the symposium discuss their work and the field

    News Briefing Schedule
    Press Office Hours and Location
    Abstracts and Embargo Policy
    Press Policies and Registration Form
    Institutional Virtual Press Room


    The 2017 Multidisciplinary Thoracic Cancers Symposium will provide participants with updates on current early phase clinical and translational initiatives in thoracic malignancies, including targeted therapy, immunotherapy, advanced radiation and surgical methodologies, and pathological advancements in molecular categorization that are relevant to daily clinical practice. Additionally, attendees will be updated on the appropriate integration of all the advancements in their daily practice, including indication, patient selection, combinations of different therapeutic modalities, prevention and management of common toxicities.

    This two-and-a-half day meeting will feature interactive case discussions; educational sessions on new multidisciplinary therapies, new targeted therapies, immunotherapy, treatment and screening guidelines, and supportive care; and oral abstract sessions highlighting the most current, evidence-based practices.


    News Briefing Schedule

    News briefings will highlight top research studies presented at the 2017 Multidisciplinary Thoracic Cancers Symposium. Registered press working remotely will be able to access live audio and slides from the news briefings and ask questions virtually. All presenter slides and an audio recording will be posted here following each briefing.

    News Briefing #1

    Advanced Predictors and Targeted Therapies
    Thursday, March 16, 2017, 12:30 – 1:15 p.m. Pacific time
    Moderator: Ravi Salgia, MD, PhD, City of Hope

    • “Tolerability and safety of thoracic radiation and immune checkpoint inhibitors among patients with lung cancer,” Kamran Ahmed, MD, Moffitt Cancer Center
    • “Heterogeneity and variation in resistance mechanisms among 223 EGFR-mutant NSCLC patients with > 1 post-resistance biopsy,” Zofia Piotrowska, MD, Massachusetts General Hospital Cancer Center
    • “Prospective trial of circulating tumor cells as a biomarker for early detection of recurrence in patients with locally advanced non-small cell lung cancer treated with chemoradiation,” Chimbu Chinniah, Perelman School of Medicine, University of Pennsylvania

    News Briefing #2

    Treatment Considerations for Focused Populations
    Friday, March 17, 2017, 1:00 – 1:45 p.m. Pacific time
    Moderator: Pranshu Mohindra, MD, University of Maryland, Baltimore

    • “Reirradiation of thoracic cancers with intensity modulated proton therapy,” Jennifer Ho, MD, MD Anderson Cancer Center
    • “Stereotactic body radiotherapy for early stage non-small cell lung cancer in patients 80 years and older: A multi-center analysis,” Richard Cassidy, MD, Winship Cancer Institute, Emory University
    • “Racial disparities in the treatment & outcome of stage I non-small cell lung cancer,” Andrew Farach, MD, Houston Methodist Hospital

    Press Office Hours and Location

    There will be an on-site press office in the Foothill F room of the San Francisco Marriott Marquis open Thursday, March 16 and Friday, March 17 from 8:00 a.m. to 4:00 p.m. Pacific time.

    Questions about the press program and press office may be directed to ASTRO’s media relations team.


    Abstracts and Embargo Policy

    All abstracts to be presented at the 2017 Multidisciplinary Thoracic Cancers Symposium are embargoed until 8:00 a.m. Pacific time on Thursday, March 16, 2017. The embargo policy applies to all abstracts regardless of whether information is obtained from another source. Failure to abide by this embargo policy may result in suspension of press credentials at the 2017 Multidisciplinary Thoracic Cancers Symposium as well as future ASTRO meetings. Questions about the embargo policy may be directed to ASTRO’s media relations team.

    The full text of the abstracts selected for oral and poster presentation will be available online at the start of the symposium.


    Press Policies and Registration Form

    Complimentary registration is available for professional journalists representing media organizations for the express purpose of gathering news and information to produce press coverage of the Symposium. Complimentary registration is open to representatives of print, broadcast and Web-based media, including health care trade media (collectively known as press), as well as public information officers from educational institutions, government agencies and nonprofit cancer research organizations presenting research at the 2017 Multidisciplinary Thoracic Cancers Symposium.

    Press Registration Form

    To register as press, journalists must submit a completed press registration form and additional information as specified below:

    • Journalists covering an ASTRO meeting for the first time must submit (1) media identification; (2) a letter of assignment from their news organization; and (3) two bylined articles.
    • Freelance journalists must submit (1) copies of two bylined, radiation oncology-related articles and (2) an official letter of assignment from an accredited news organization.
    • Newsletter journalists must submit copies of two issues of their newsletter containing at least one bylined article in each issue. If a representative was registered as press at a previous ASTRO meeting or symposium, one of the issues submitted must illustrate the resulting editorial coverage.
    • Television and/or radio crews must present valid press credentials from their respective media outlets. Camera crews and photographers must be escorted on-site at all times by a representative of ASTRO’s media relations team. For more information, please review ASTRO’s Photography, Videotaping and Recording Policies, available emailing ASTRO's media relations team.
    • Public information officers of educational institutions, government agencies and nonprofit cancer research organizations presenting research at the 2017 Multidisciplinary Thoracic Cancers Symposium are welcome to receive complimentary registration as press upon submitting (1) a completed press registration form; (2) a business card; and (3) the abstract title and presenting author name for the study being presented.
    • Exhibitors are not permitted to register as press unless they can provide proof of editorial assignment from an accredited news organization that meets the above criteria.

    For medical publishing companies, the publication must meet the following criteria to obtain press access:

    • Must have a regular editorial news section;
    • Must have multiple sponsors (no single-sponsor publications); and
    • Must have complete editorial freedom from their sponsors.

    For online news outlets (including blogs), the news-making organization or private blog must meet the following criteria to obtain press access:

    • The website must provide original, editorial news coverage;
    • Editorial content must be independent of advertising and sponsorship;
    • Advertising on the website must be clearly identified as such;
    • Any sponsors of the website must be clearly identified as such and should be multiple in number (i.e., no single-sponsored websites); and
    • Online press credentials are subject to review by ASTRO’s media relations office.

    Public relations, marketing and/or advertising representatives, financial analysts, book publishers and book authors, and individuals from communications, print or online promotion services are welcome to register as regular attendees, however, they are not permitted to register as press.

    ASTRO reserves the right to bar from this and future meetings any journalist who fails to adhere to these policies or who misuses his/her press privileges to engage in activities other than journalistic pursuits.


    Institutional Virtual Press Room

    ASTRO provides an exclusive virtual press room for academic, public and private institutions presenting research at the 2017 Multidisciplinary Thoracic Cancers Symposium. The Institutional Virtual Press Room is the online gateway to the on- and off-site reporters who are covering the meeting. Please note that there is not a physical, on-site press room for institutions, and printed materials will not be accepted for distribution. Email ASTRO’s media relations team with any questions about the Institutional Virtual Press Room or to submit materials for inclusion.